A. David Smith

University of North Carolina at Chapel Hill

Also affiliated with University of Leeds, Emory University, UNC Lineberger Comprehensive Cancer Center, New York University, Icahn School of Medicine at Mount Sinai

NeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?”.

The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?

Alzheimer s & Dementia(2021)10.1002/alz.12393

N/A

0DataRank · unranked

11 citations

Hiroko H. Dodge, Sarah‐Naomi James, Gregory A. Jicha, Pierre‐François Meyer, Marcus Richards +9 more

Association between differences in body-weight based dose versus actual propofol dosages administered for oocyte retrieval on hemodynamic parameters and reproductive outcomes

Proceedings in Obstetrics and Gynecology(2025)10.17077/2154-4751.34426

N/A

0DataRank · unranked

0 citations

Aditi Katwala, Haley Steffen, Karen M. Summers, Alexis Ireland, A. David Smith +7 more